3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Waldenstrom Macroglobulinemia
1
Solitary Fibrous Tumor, Pleural
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Glioma
1
Fallopian Tube Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Chondrosarcoma, Mesenchymal
1
Chondrosarcoma, Clear Cell
1
Chondrosarcoma
1
Anemia
1
Anatomic Stage III Breast Cancer AJCC v8
1
Adult Patients Who Are Receiving Oncologic Care
1
Interventions
Dexamethasone
7
Bortezomib
6
Cyclophosphamide
5
daratumumab
3
Specimen Handling
3
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
3
venetoclax
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
belantamab mafodotin
2
auricularum
2
X-Rays
2
Phantoms, Imaging
2
Magnetic Resonance Spectroscopy
2
Clinical Protocols
2
Calcium Dobesilate
2
Biopsy
2
ixazomib
1
Tissue Banks
1
Stem Cell Transplantation
1
Pharmaceutical Preparations
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoglobulin Light-chain Amyloidosis
×
Pharmacogenomic Testing
×
90 days
×
Clear all
No trials found.